Induced Pluripotent Stem Cell (Ipsc) Market Transformative Growth Ahead to Reach USD 4,355.56 Million by 2032, Growing at 9.4% CAGR | Key Players-Ncardia,REPROCELL Inc.,Takara Bio Inc.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

• The induced pluripotent stem cell (iPSC) market size was valued at USD 1,940.39 million in 2023
• The market is expected to expand at a CAGR of 9.4% from 2024 to 2032.
• The industry is expected to grow to USD 4,355.56 million by 2032.

𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

Induced pluripotent stem cells, or iPSCs, are cells derived from adult somatic tissues that can be reprogrammed by adding specific genes and substances. The reprogramming process allows the iPSCs to acquire pluripotent properties similar to those of embryonic stem cells. iPSCs are a helpful tool for sickness modeling because of their capacity to reprogram cells from the same individual. To transfer the genes and other components needed for iPSC reprogramming, they are used as vectors. Numerous fields, including gene therapies, toxicity studies, drug development, and disease modeling, are employed.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐀 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐓𝐨 𝐆𝐚𝐢𝐧 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.polarismarketresearch.com/industry-analysis/induced-pluripotent-stem-cell-ipsc-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:

Identifying novel cellular technologies that correctly imitate and reflect human physiology is a significant challenge in tissue engineering research. In recent years, scaffold technology has evolved successfully to meet this difficulty. It is predicted to drive consistent growth during the projection period. Furthermore, scaffold technologies have demonstrated promise in achieving the goal of tissue engineering: restoring and maintaining the function of injured organs. An increase in demand for in vitro tissue constructs that coordinate several biological functions, such as nutrition transport and mechanical stability, is projected to propel the scaffold technology market forward.

𝐊𝐞𝐲 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬:

Because there are so many companies in the industry, it is expected to be both competitive and fragmented. Some of the major players participating in the induced pluripotent stem cell (iPSC) market:
• Astellas Pharma Inc.
• Axol Bioscience Ltd.
• Cynata Therapeutics Limited
• Fate Therapeutics
• FUJIFILM Holdings Corporation (Cellular Dynamics)
• Ncardia
• REPROCELL Inc.
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• ViaCyte, Inc

𝐂𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐁𝐞𝐥𝐨𝐰 𝐋𝐢𝐧𝐤 𝐭𝐨 𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/buy/803/2

𝐂𝐨𝐮𝐧𝐭𝐫𝐲-𝐖𝐢𝐬𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea, Australia)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐊𝐞𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐈𝐧𝐝𝐮𝐜𝐞𝐝 𝐏𝐥𝐮𝐫𝐢𝐩𝐨𝐭𝐞𝐧𝐭 𝐒𝐭𝐞𝐦 𝐂𝐞𝐥𝐥 (𝐢𝐏𝐒𝐂) 𝐌𝐚𝐫𝐤𝐞𝐭

• Advancements in Reprogramming Technologies: Continuous improvements in reprogramming methods are making it easier, faster, and safer to generate iPSCs from adult cells. Techniques such as non-integrative methods using episomal vectors, Sendai virus, or mRNA are reducing the risk of genetic mutations and enhancing the quality of iPSCs.
• Integration with Gene Editing Technologies: The combination of iPSCs with gene editing tools like CRISPR/Cas9 is revolutionizing the field. This integration allows precise genetic modifications, enabling the correction of disease-causing mutations and the creation of more accurate disease models for drug discovery and development.
• Growing Focus on Personalized Medicine: The personalized medicine approach is gaining traction, with iPSCs playing a crucial role. iPSCs derived from individual patients are used to develop patient-specific disease models, facilitating tailored therapies and reducing the risk of adverse reactions.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/induced-pluripotent-stem-cell-ipsc-market

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

The induced pluripotent stem cell (iPSC) market is mainly segmented based on derived cells, workflow, application, and region. Based on the derived cell line, cardiomyocytes became the prominent segment in the global market in 2023 because they are the specialized muscle cells of the heart that are responsible for contraction and pumping. They are critical for heart function and the prevention of cardiovascular diseases (CVDs). With the increasing global frequency of CVDs, there is a growing desire for novel medicines that target cardiomyocytes to treat a variety of cardiac ailments. Furthermore, according to regional research, the regenerative medicine market is expected to experience significant expansion in the next years.

By Derived Cell
• Hepatocytes
• Fibroblasts
• Neural Cells
o Excitatory Neurons
o Inhibitory Neurons
• Amniotic Cells
• Cardiomyocytes
• Others

By Workflow
• Reprogramming
• Cell Culture
• Cell Characterization / Analysis
• Engineering
• Others

By Application
• Manufacturing
• Academic Research
• Drug Development & Discovery
• Toxicity Screening
• Regenerative Medicine

𝐢𝐏𝐒𝐂 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• In 2023, the global market witnessed significant growth, with cardiomyocytes emerging as the dominant segment. This is because cardiomyocytes, specialized muscle cells in the heart responsible for its contraction and pumping action, have gained significant attention due to their potential for therapeutic applications.
• The regenerative medicine industry is projected to experience a substantial growth rate in the upcoming years. Regenerative medicine involves therapeutic techniques that target the repair, replacement, or regeneration of tissues or organs in order to restore normal function in individuals who are suffering from injury or disease.
• The North American region dominated the global market, owing to its extensive research and innovation in the field of biomedical science.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐖𝐢𝐝𝐞-𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐟 𝐏𝐌𝐑'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Tumor Ablation Market: https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market

Drug Discovery Informatics Market: https://www.polarismarketresearch.com/industry-analysis/drug-discovery-informatics-market

Xerostomia Therapeutics Market: https://www.polarismarketresearch.com/industry-analysis/xerostomia-therapeutics-market

Anesthesia Devices Market: https://www.polarismarketresearch.com/industry-analysis/global-anesthesia-devices-Market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.